S-8 S-8 EX-FILING FEES 0001356576 SUPERNUS PHARMACEUTICALS, INC. N/A Fees to be Paid 0001356576 2026-06-18 2026-06-18 0001356576 1 2026-06-18 2026-06-18 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

SUPERNUS PHARMACEUTICALS, INC.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common Stock, $0.001 par value per Share ("Common Stock") Other 4,000,000 $ 44.10 $ 176,400,000.00 0.0001381 $ 24,360.84

Total Offering Amounts:

$ 176,400,000.00

$ 24,360.84

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 24,360.84

Offering Note

1

(1a) Fee calculated in accordance with Rules 457(c) and (h) under the Securities Act of 1933, as amended (the "Securities Act"). (1b) Pursuant to Rule 416(a) under the Securities Act of 1933, this Registration Statement also covers such additional shares of Common Stock, of Supernus Pharmaceuticals, Inc. (the "Registrant"), as may be issued by reason of a stock dividend, recapitalization, stock split, or combination or exchange of shares or similar transactions. (1c) Estimated pursuant to Rule 457(c) and (h) solely for the purposes of calculating the Maximum Aggregate Offering Price and the Amount of Registration Fee based upon the average of the high and low prices of the Registrant's Common Stock as reported on the NASDAQ Global Market on June 18, 2026.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims
Fee Offset Sources